SCHEMBL9619145

SCHEMBL9619145

CCCc1nc(NO)nc(N2CCOCC2)n1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.50
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 3/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.44
HRH4 Q9H3N8 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MAPK1 P28482 2/20 0.43
TSHR P16473 2/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPT P10636 1/20 0.42
HTT P42858 2/20 0.42
LMNA P02545 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9619171 0.87 SMN1; SMN2 (0.57) GAAKDM4EALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL10418857 0.86 SMN1; SMN2 (0.56) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL9619146 0.84 KDM4E (0.55) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL9619063 0.84 KDM4E (0.52) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL3365592 0.84 CYP1A2 (0.56) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL9619085 0.83 ALDH1A1 (0.46) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL8798665 0.82 NPSR1 (0.46) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL9619183 0.82 KDM4E (0.50) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL9619060 0.82 KDM4E (0.50) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL9619057 0.82 KDM4E (0.50) GAAKDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0356412-B1 USE OF 2-AMINO-4-MORPHOLINO-6-PROPYL-1,3,5-TRIAZINES IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF COGNITIVE AND MENTAL DISORDERS U C B, S.A. (BE) 1992-05-13 EP claimed
EP-0356413-B1 2-AMINO-4-MORPHOLINO-6-PROPYL-1,3,5-TRIAZINES U C B, S.A. (BE) 1992-01-29 EP claimed
US-4956363-A 2-amino-4-morpholino-6-propyl-1,3,5-triazine U C B S.A. (BE) 1990-09-11 US claimed
US-4956367-A COGNITION ACTIVATORS, ALZHEIMER*S DISEASE U C B S.A. (BE) 1990-09-11 US claimed
EP-0356412-A1 Use of 2-amino-4-morpholino-6-propyl-1,3,5-triazines in the preparation of a medicament for the treatment of cognitive and mental disorders U C B, S.A. (BE) 1990-02-28 EP claimed
EP-0356413-A1 2-Amino-4-morpholino-6-propyl-1,3,5-triazines U C B, S.A. (BE) 1990-02-28 EP claimed
EP-0356412-B1 USE OF 2-AMINO-4-MORPHOLINO-6-PROPYL-1,3,5-TRIAZINES IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF COGNITIVE AND MENTAL DISORDERS U C B, S.A. (BE) 1992-05-13 EP disclosed
EP-0356413-B1 2-AMINO-4-MORPHOLINO-6-PROPYL-1,3,5-TRIAZINES U C B, S.A. (BE) 1992-01-29 EP disclosed
US-4956363-A 2-amino-4-morpholino-6-propyl-1,3,5-triazine U C B S.A. (BE) 1990-09-11 US disclosed
US-4956367-A COGNITION ACTIVATORS, ALZHEIMER*S DISEASE U C B S.A. (BE) 1990-09-11 US disclosed
EP-0356412-A1 Use of 2-amino-4-morpholino-6-propyl-1,3,5-triazines in the preparation of a medicament for the treatment of cognitive and mental disorders U C B, S.A. (BE) 1990-02-28 EP disclosed
EP-0356413-A1 2-Amino-4-morpholino-6-propyl-1,3,5-triazines U C B, S.A. (BE) 1990-02-28 EP disclosed